NeuBase Therapeutics, Inc.
NBSEDelisted May 16, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001173281
NeuBase Therapeutics, Inc. was delisted on May 16, 2024; its insiders filed their last Form 4 on Sep 18, 2023; 18 institutions reported holding it in 13F filings for Q1 2024, worth $177.1K in total; Greenlight Capital was the only superinvestor holding it.
Superinvestors holding NBSE, Q1 2024
1 superinvestor reports holding NeuBase Therapeutics, Inc. on Form 13F, worth $61.3K in total. Weight is NeuBase Therapeutics, Inc.'s share of each 13F portfolio; actions compare shares with Q4 2023.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Greenlight CapitalDavid Einhorn | <0.1% | 136,350 | $61.3K | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of NBSE each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2021
1 superinvestor holding at quarter end
- Added
- Greenlight Capital (+34.5%)